These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1450486)

  • 1. Administration of GSH has no influence on the RBC membrane: oxidative damage to patients on hemodialysis.
    Taccone-Gallucci M; Lubrano R; Clerico A; Meloni C; Morosetti M; Meschini L; Elli M; Trapasso E; Castello MA; Casciani CU
    ASAIO J; 1992; 38(4):855-7. PubMed ID: 1450486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E supplementation and oxidative status of peripheral blood mononuclear cells and lymphocyte subsets in hemodialysis patients.
    Lubrano R; Taccone-Gallucci M; Piazza A; Morosetti M; Meloni C; Citti G; Mannarino O; Castello MA; Casciani CU
    Nutrition; 1992; 8(2):94-7. PubMed ID: 1591459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
    Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
    ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte transmembrane electron transfer in haemodialysis patients.
    Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
    Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
    J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
    Müller C; Eisenbrand G; Gradinger M; Rath T; Albert FW; Vienken J; Singh R; Farmer PB; Stockis JP; Janzowski C
    Free Radic Res; 2004 Oct; 38(10):1093-100. PubMed ID: 15512797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disappearance of oxidative damage to red blood cell membranes in uremic patients following renal transplant.
    Taccone-Gallucci M; Lubrano R; Belli A; Meloni C; Morosetti M; Meschini L; Elli M; Boffo V; Pisani F; Giardini O
    ASAIO Trans; 1989; 35(3):533-5. PubMed ID: 2597526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentose-phosphate shunt activity and red blood cell malonyldialdehyde levels in haemodialysis and in CAPD patients.
    Taccone-Gallucci M; Giardini O; Lubrano R; Mazzarella V; Bandino D; Meloni C; Elli M; Citti F; Cozzari M; Buoncristiani U
    Life Support Syst; 1985; 3 Suppl 1():121-4. PubMed ID: 3870550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell membrane lipid peroxidation and chronic haemolysis in haemodialysis patients.
    Taccone-Gallucci M; Lubrano R; Mazzarella V; Bandino D; Meloni C; Morosetti M; Elli M; Giardini O; Boffo V; Tozzo C
    Life Support Syst; 1985; 3 Suppl 1():41-4. PubMed ID: 3870599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
    Soejima A; Matsuzawa N; Miyake N; Karube M; Fukuoka K; Nakabayashi K; Kitamoto K; Nagasawa T
    Clin Nephrol; 1999 Feb; 51(2):92-7. PubMed ID: 10069644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients.
    Usberti M; Lima G; Arisi M; Bufano G; D'Avanzo L; Gazzotti RM
    J Nephrol; 1997; 10(5):261-5. PubMed ID: 9364318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracorporeal hemodialysis: various++ metabolic and erythrocyte-membrane features of uremic subjects].
    Galli F; Cavezza G; Biagiarelli B; Pascucci M; Galiotta P; Canestrari F
    Boll Soc Ital Biol Sper; 1993 Jan; 69(1):1-6. PubMed ID: 8329184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
    Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
    Jacobson SH; Moldéus P
    Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication.
    Zachée P; Ferrant A; Daelemans R; Goossens W; Boogaerts MA; Lins RL
    Nephron; 1995; 71(3):343-9. PubMed ID: 8569984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthocyanin/polyphenolic-rich fruit juice reduces oxidative cell damage in an intervention study with patients on hemodialysis.
    Spormann TM; Albert FW; Rath T; Dietrich H; Will F; Stockis JP; Eisenbrand G; Janzowski C
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3372-80. PubMed ID: 19064553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different dialysis membranes on oxidative stress and selenium status.
    Yavuz O; Bicik Z; Cinar Y; Guney Y; Guler S
    Clin Chim Acta; 2004 Aug; 346(2):153-60. PubMed ID: 15256316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.